Expression of gp39 on activated T cells provides a co-stimulatory signal in peripheral lymphoid tissue that regulates humoral and cell-mediated immunity. The function of gp39 and its receptor CD40 in thymus remains uncertain. Here we report that overexpression of gp39 in transgenic mouse thymus caused a dose-dependent decline in thymocyte numbers (Ͼ500 fold), loss of cortical epithelium and expansion of CD40 ⍣ medullary cells. Transplantation of transgenic bone marrow into normal mice indicated that gp39 significantly diminished thymocyte viability in the context of a 'normal' thymic environment. The peripheral tissues of transgenic mice also accumulated abnormalities in a transgene dose-dependent manner that involved inflammation and lymphoid tissue hypertrophy. Animals with the highest transgene copy numbers acquired a lethal inflammatory bowel disease marked by the infiltration of gp39 ⍣ T cells and CD40 ⍣ cells into diseased tissues. Examination of cells overexpressing gp39 suggested that these defects were caused, in part, by the saturation of a mechanism that sequesters gp39 inside non-activated cells and thus protects the immune system from inappropriate gp39-CD40 interaction. These results establish a regulatory role for gp39 in thymus function and a causal relationship in mediating chronic inflammatory disease.
Introduction

Mobilization of gp39 (CD40L, T-BAM, TRAP) on activated T
Another series of immunological responses dependent on gp39-CD40 signaling affect inflammation. For instance, CD40 cells regulates numerous immune responses in peripheral lymphoid tissue. The requirement for this cell surface molecule stimulation within the vasculature at sites of inflammation controls a variety of changes in endothelial cell function (6-and its receptor CD40 was initially established for thymusdependent humoral immunity where mutations in the gp39 8). Engagement of CD40 on human monocytes induces the expression of proinflammatory cytokines including tumor and CD40 genes cause deficiencies in Ig class switching and germinal center formation (1) (2) (3) . Examination of the necrosis factor-α, IL-1 and IL-8, and the up-regulation of various cell surface molecules such as MHC II, CD54 and functional consequences of CD40 binding has identified numerous changes in B cell proliferation and differentiation, CD86 (9-11). The nitric oxide response is an additional effector function of macrophages that is diminished in gp39-and the specificity of these B cell responses can vary depending on secondary cytokine-and cell surface-mediated deficient mice (12), and the persistent neutropenia and susceptibility to infections associated with mutations in gp39 signals (4) . The cellular interactions that initiate the primary humoral response occur in specific locations in secondary (13,14) is a further demonstration that this molecule is required for normal cell-mediated immune responses. In addition, gp39 lymphoid tissue and T cells within the spleen transiently express gp39 along the periarteriolar lymphocyte sheaths may even contribute to pathological states of inflammation.
Several mouse models of inflammatory bowel disease (IBD) (PALS) and terminal arterioles (5). have suggested that dysfunctional T cells, generated by gene
Transgene expression disruption (15-17) or following aberrant thymic selection (18), Transgene expression was measured by RT-PCR. Total RNA respond inappropriately to the normal constituents of the gut.
(5 µg), prepared from pooled spleen and lymph node lymphoFeatures of this immune response which include a large cytes, was annealed with oligo(dT)12-18 and then incubated accumulation of macrophages, B cells and T cells are thought in the presence and absence of reverse transcriptase (Superto involve exaggerated T h 1-and T h 2-related activities (19-script; Gibco/BRL, Grand Island, NY) and 10 mM dNTPs for 21); however, many of the intercellular signals mediating IBD 1 h at 42°C. First-strand cDNA was amplified with a thermal in these models have not been fully defined. Clearly, gp39
cycling machine (Perkin-Elmer Cetus, Norwalk, CT) for 25 has the potential to drive myeloid and B cell hyperactivity.
cycles at an annealing temperature of 60°C in the presence The demonstration that anti-gp39 antibodies effectively block of 2.5 mM MgCl and 25 mM dNTPs. The primers amplified collagen-induced arthritis (22) is consistent with its involvethe junction between the murine gp39 cDNA starting 200 bp ment in an inflammatory disease such as colitis.
from the 3Ј end (5Ј-AGCATTGGATCTGAGAGAATC-3Ј) and In contrast to peripheral tissues, the role of the gp39-CD40 the third exon of the human growth hormone gene (5Ј-co-stimulatory pathway in primary lymphoid tissue such as CTCCCTGTTGGAGGGTGTCGG-3Ј) which lies 790 bp down the thymus remains uncertain. Immunohistochemistry of stream of the BamHI splice site (28) . RNA samples were human (23) and mouse tissue has shown that CD40 is pretreated with RNase-free DNase (Stratagene, La Jolla, CA) expressed on cortical and medullary epithelial cells, as well to prevent contamination with cellular DNA. Each sample was as thymic interdigitating or dendritic cells. It was further assayed in the absence of reverse transcriptase to ensure demonstrated that CD40 gene expression could be regulated that PCR priming originated from first-strand cDNA and in thymic epithelium and that its cross-linking could cothe positive controls for first-strand DNA synthesis involved stimulate cytokine production (23). Despite this, no overt measurement of HGPRT gene expression using the following differences in thymocyte cellularity were observed in gp39-primers: 5Ј-CACAGGACTAGAACACCTGC-3Ј and 5Ј-AGAand CD40-deficient mice (2, 3) . Subsequent experiments AGCAATGCTGTCACCTTCCCC-3Ј. All PCR products were using neutralizing anti-gp39 antibodies in combination with subcloned and sequenced to confirm their identity. Five mouse models of negative selection provided evidence that microliters of all PCR reaction products were run on a 2% CD40 signaling can influence T cell repertoire (24) , and the agarose minigel and stained with ethidium bromide. Two mice impairment of T h function in gp39-deficient mice (25,26) has from each transgenic line were assayed. raised the possibility that CD40 engagement may influence additional aspects of T cell development. As an alternative
Thymus reconstitutions method for testing the regulatory activities of gp39 in thymus Thy-1.1 B6 mice were subjected to γ-irradiation (1000 rad) and peripheral lymphoid tissue we targeted the expression and injected (i.v.) with 100 µl of PBS containing 10 7 cells of this molecule in transgenic mice using a T cell lineagederived from the femurs of control Thy-1.2 B6 mice or Thyspecific gene promoter. Here we show that gp39 overexpres-1.2 Lckgp39 (line 10967; 40 transgene copies). Mice were sion effectively limits thymocyte viability and causes chronic sacrificed after 4 weeks. Cells from the thymus, spleen and inflammatory disease. We also present evidence for a mechanmesenteric node were isolated, counted and then analyzed ism that sequesters gp39 inside non-activated cells that may by FACS. All animals receiving bone marrow were rescued protect the immune system from inappropriate gp39-CD40 from the lethal effects of the irradiation. No differences in interaction.
health were observed between animals receiving transgenic and non-transgenic bone marrow and total cellularity of peripheral lymphoid tissues between these groups was Methods equivalent.
Transgenic mice FACS analysis
The murine gp39 cDNA (27) was cloned by PCR and ligated into the BamHI site of p1017 which lies between the proximal Transgenic and control tissues were disrupted, and the released cells were collected in medium, counted and stained promoter of the mouse lck gene and the exon/intron portion of the human growth hormone gene (28) . Following NotI with saturating concentrations of antibody at 4°C for 1 h. Specific cell surface molecules were examined with the digestion and fragment purification, the Lckgp39 transgene was injected at 10 ng/µl into (C57BL/6NϫC3H/HeN)F 2 mouse following antibodies: phycoerythrin (PE)-conjugated anti-CD4 (RM4-5), FITC-labeled anti-CD8 (53-6.7), FITC-labeled antizygote pronuclei. Transgenic founders were identified following hybridization of tail DNA with a probe radioactive for the CD3ε (145-2C11), PE-conjugated anti-CD45R/B220 (RA3-6B2), FITC-labeled anti-I-A b (25-9-3), FITC-labeled anti-CD5 hGH sequences present within the transgene. Transgenic lines were generated by backcrossing founders with C57BL6
(53-7.3) (PharMingen, San Diego, CA). Analyses were performed with a FACScan flow cytometer (Becton Dickinson, mice. Gene copy number was measured following hybridization of non-transgenic and transgenic DNA with a radioactive Mountain View, CA) using Lysys II software. Thymocytes from transgenic line 7918 (three copies) and non-transgenic probe for the mouse gp39 gene. Purified DNA (2 µg) from three mice within each lineage was denatured and spotted littermates were assayed for gp39 using digoxigenin-conjugated MR1 (29) and a FITC-conjugated anti-digoxigenin antiin duplicate onto nitrocellulose and hybridized overnight. Filters were then washed and the samples were quantitated body (1207741; Boehringer Mannheim, Indianapolis, IN). Intracellular gp39 was assayed following permeabilization by phosphor image analysis. with saponin (30) . For activation studies, thymocytes (1ϫ10 6 ) were cultured in HEPES-buffered saline solution plus 10% FBS in the presence or absence of phorbol myristate acetate (PMA) (10 µg/ml) and ionomycin (10 mM). At the indicated times cells were placed on ice and then assayed for antigp39 binding using the gate settings established in (Fig. 4a) . Each point represents the average Ϯ SD of three experiments.
Immunohistochemical analysis
Immunohistochemistry of frozen sections was performed as previously described (31) . Specific binding of ER-TR4, anti-CD40 (Serotec, Kidlington, UK) was detected by sequential application of goat anti-hamster or goat anti-rat antibodies (Pierce, Rockford, IL) that had been modified by treatment with NHS-digoxigenin followed by peroxidase-conjugated Fab anti-digoxigenin antibody fragments (Boehringer Mannheim). Enzyme activity was demonstrated with 3,3Ј-diaminobenzidine. For analysis of glomerulopathy we mounted 6 µm thick, formalin-fixed, paraffin-embedded sections on Fisher Plus slides. The sections were deparaffinized and hydrated prior to immunostaining. Staining was carried out by first blocking the tissue for endogenous tissue substances using 3% hydrogen peroxide in PBS, avidin, biotin and normal mixed serum, each for 10 min. PBS rinse was used between each step. Then, 1:100 biotinylated anti-mouse IgG primary antibody (Sigma M-5899) was applied for 2 h at room temperature, followed by an avidin-linked peroxidase enzyme labeled with diaminobenzidine tetrahydrochloride and counterstained with hematoxylin. Control slides, consisting of substitution of the primary antibody with mixed normal serum, were negative. a dose-dependent manner (32), and we observed a strong correlation between the number of transgenes carried by these mice and a diminution in thymus cellularity (Fig. 1) . Animals with Ͻ12 copies of the transgene had 2-to 10-fold typical ratio in normal thymus (4:1). The predominant cell type within these altered thymuses were actually B lymphocytes fewer thymocytes than control mice. The decline in cell numbers occurred equally in the various classes of immature (Fig. 1C) ;~80% of the 1-2ϫ10 6 cells recovered from high transgene copy number mice were B220 ϩ , MHC II ϩ , Ig ϩ and (CD4 ϩ CD8 ϩ ) and mature (CD4 ϩ CD8 -and CD4 -CD8 ϩ ) thymocytes, and their relative frequencies remained similar to control CD5 -. The severe disruption of thymocyte development in mice, thus suggesting that thymocyte differentiation was maintained in these small thymuses. In higher copy number Lckgp39 mice was paralleled by a dramatic change in thymic stromal cell composition. Most prominent in mice containing mice, however, the Lckgp39 transgene had a more pronounced effect on CD4 ϩ CD8 ϩ cells. Double-positive cells in the highest number of transgenes was the loss of cortical epithelium, as defined by staining with ER-TR4 mAb (33) line 7913 (50 transgenes), for instance, declined from the averaged control value of 1.4ϫ10 8 to 2.5ϫ10 4 cells (~5000- (Fig. 2c) , and an expanded reactivity with the ER-TR5 and 10.1.1 anti-thymic stromal cell mAb that selectively label fold), whereas CD4 ϩ CD8 -and CD4 -CD8 ϩ cells decreased 70-fold from an average 1.4ϫ10 7 in control thymuses to medullary but not cortical or subcapsular epithelium (31, 34) . Areas of concentrated CD40 expression which delineate the 2.0ϫ10 5 cells (Fig. 1B) . The ratio of CD4 ϩ CD8 -to CD4 -CD8 ϩ thymocytes in transgenic tissue (1:2) also deviated from the medullary compartment in the normal thymus were confluent throughout this transgenic tissue (Fig. 2e) . The non-resident overexpression significantly diminished T cell development in the context of a 'normal' thymic environment. B cells that lacked CD5 were found in follicle-like clusters within the subcapsular regions of the cortex (data not shown).
Results
Dose-dependent loss of thymocytes in Lckgp39 transgenic
gp39 protein is sequestered inside thymocytes and released This perturbation in thymic architecture is unique when comto the cell surface following activation pared to other strains of mice with deficiencies in T cell development. Mutations that prevent differentiation beyond When viable thymocytes from line 7918 (three transgene copies) were assayed by cytofluorimetry only 2-6% stained the very immature CD4 -CD8 -thymocyte stage lead to thymuses that retain cortical ER-TR4 ϩ cells but lack medullary with anti-gp39 mAb MR1 (29) (Fig. 4A) . However, gp39 protein could be detected within 90% of these cells following permeaepithelium (35,36), thus arguing that early stage thymocytes help maintain the cortical compartment and that the absence bilization (Fig. 4B ). The expression of gp39 following T cell activation is generally assumed to result from induced gene of mature thymocytes accounts for the loss of medullary stroma. The opposite condition exists for the Lckgp39 thymus, transcription. Since activity of the proximal Lck promoter is constitutive in thymocytes and not coupled to cell activation, where there is a preferential decline in immature thymocytes and cortical epithelium but retention of a modified medullary this selective accumulation of gp39 within transgenic cells was unexpected. We therefore tested whether gp39 transport compartment.
Positive selection of immature thymocytes is dependent on to the cell surface was activation-dependent in vitro. Following incubation at 37°C in untreated culture medium the frequency cortical epithelium (37, 38) and the loss of this cell type could account for the dramatic decline in Lckgp39 thymocytes.
of gp39 ϩ cells increased to~50% within 2 h (Fig. 4C ). This response argues that interactions within the thymic environTherefore, to examine the fate of transgenic thymocytes in the context of a normal thymic environment, we reconstituted ment down-regulate surface levels of gp39, possibly as a consequence of CD40-mediated endocytosis (39) . However, a lethally irradiated B6 (Thy-1.1) mice with bone marrow derived from Lckgp39 animals (Thy-1.2). Four weeks later, the number much more rapid delivery of gp39 was achieved by activating agents; Ͼ80% of the cells were gp39 ϩ just 15 min after of viable thymocytes recovered from animals receiving Lckgp39 bone marrow was reduced Ͼ20-fold and the number treatment with PMA and ionomycin and the maximum effect was reached within 1 h. A similar phenomenon was observed of dead cells relative to controls was increased by 7-fold (Fig. 3A) . Examination of these cells by FACS indicated that in non-transgenic thymocytes, where following permeabilization the frequency of gp39 ϩ cells increased from 0.5 to 8% the relative percentages of CD4 -CD8 -and CD4 ϩ CD8 ϩ cells were normal, as was the combined percentage of CD4 ϩ CD8 -( Fig. 4A and B) , and an equivalent percentage of intact cells expressed gp39 following 1 h treatment with PMA and and CD4 -CD8 ϩ cells (Fig. 3B) . In contrast to the control animals, however, there was a shift in the ratio of CD4 ϩ CD8 -ionomycin (Fig. 4D) . These results indicate that gp39 protein is sequestered within normal and transgenic thymocytes and and CD4 -CD8 ϩ cells similar to that seen in transgenic mice (Fig. 1) , and the level of CD3 expression in these cells transported to the cell surface upon activation. A similar phenomenon has been reported in human tonsillar T cells (40). was abnormally low. This result demonstrates that gp39 One notable difference between non-transgenic and transtransgenes), and three non-breeding founder mice with 60, genic cells was the ability of gp39 to reach the cell surface 40 and 25 copies of the transgene had macroscopic changes in vitro without activation (compare Fig. 4C and D) . This of thickened large intestine. Light microscopic changes were response was minimal in non-transgenic thymocytes but characterized by a superficial to transmural non-suppurative increased proportionally to transgene copy number and to granulomatous infiltrate that was accompanied by multifocal approached the high level expression achieved in activated ulcerations and glandular loss/dysplasia ( Fig. 5A and B) . The transgenic cells. Thus, the percentage of gp39 ϩ thymocytes colon was the anatomic segment most severely affected; the from mouse lines containing five, 25 and 40 copies of the inflammation extended in a non-segmented retrograde fashion transgene after 15 min incubation in culture medium was and involved the stomach in some animals. Myeloid hyperplarespectively 19, 44 and 65%. The dose-dependent elevation sia was observed in the bone marrow and erythroid extraof surface gp39 observed in transgenic thymocytes suggests medullary hematopoiesis occurred in the spleen, a factor that the mechanism sequestering gp39 is saturable; in high contributing to the splenomegaly. Another salient feature was copy number transgenic mice gp39 transport becomes unresa membranous glomerulopathy that increased in severity with tricted and the elevated surface expression elicits the severe increased transgene copy number and whose occurrence thymic phenotype. Consistent with this model is the fact that most likely resided in exaggerated B cell function. Light the surface levels of gp39 on freshly isolated thymocytes microscopic changes were characterized by a uniform, diffuse increased with transgene copy number (Fig. 4E-H) .
thickening of the glomerular capillary wall accompanied by an increase in mesangial matrix. The deposition of IgG Lckgp39 transgenic mice develop IBD and lympho-hematoin these glomeruli was confirmed by immunohistochemistry poietic alterations ( Fig. 5E and F) . Several profound changes in the peripheral tissues of Lckgp39
The onset of colitis within these animals was rapid, with mice were observed and, similar to the thymus, the severity diarrhea being detected between 3 and 6 weeks of age. of these phenotypes increased as a function of transgene Lesions containing Helicobacter hepaticus, an infective agent copy number. The most prominent histopathologic change previously associated with murine colitis (41), were not was a pronounced mononuclear cell infiltrate in various tisobserved in Lckgp39 mice. When examined by immunohistosues, including the lung, liver, pancreas and gastrointestinal chemistry, the diseased gut of Lckgp39 mice contained large tract (Fig. 5) . The severity and extent of this inflammation accumulations of gp39 ϩ cells (Fig. 6A ). This same region increased to where mice with the highest transgene copy stained intensely with anti-CD40 antibodies (Fig. 6B) and a numbers developed a lethal wasting disease with morphologic subset of these cells were B lymphocytes as defined by features of chronic IBD. To date, six out of six mice from line 7913 (50 transgenes), 12 out of 25 mice from line 10951 (27 staining with B220 antibodies (Fig. 6C) . Many of the remaining CD40 ϩ B220 -cells also bound mAb N418 which stains macrophages and dendritic cells (42). The prevalent numbers of gp39 ϩ cells in diseased gut raised questions concerning the activity of the Lckgp39 transgene in peripheral lymphoid tissues. Accordingly, we prepared RNA from pooled spleen and lymph node lymphocytes from low and high transgene copy number mice and performed RT-PCR using primers specific for the Lckgp39 transgene (Fig. 7A) . As shown in Fig. 7(B) , PCR products were readily detectable in samples prepared from line 10951 (27 copies) and 10967 (40 copies), but were much less apparent in low copy number lines 7918 (three copies) and 7931 (five copies). However, the presence of these DNA fragments in low copy number samples was confirmed by increasing the amplification cycles of the PCR and by Southern blot analysis. We subcloned the most prevalent band at 535 bp, and three other PCR products of 735, 790 and 990 bp. DNA sequencing indicated that these originated from four processed forms of Lckgp39 RNA. To determine whether peripheral lymphocytes in higher copy number mice contained elevated gp39 protein we incubated cells from control and transgenic mesenteric nodes briefly in vitro to enhance surface expression, and performed two-color FACS using antibodies for CD5 and gp39. As indicated in Fig. 7(C) , transgenic T cells contained significantly more gp39 protein than controls. These results argue that the Lckgp39 transgene remains active in a portion of peripheral T cells and that this may contribute to the peripheral phenotypes in these mice.
Accompanying the apparent increase in peripheral transgene expression, we observed that the secondary lymphoid tissues of Lckgp39 mice grew significantly in size and deviated in normal cellular composition. For example, the number of mesenteric node B cells increased exponentially over the range of mouse lines (Fig. 8A) . T cell numbers, when compared to control littermates, were reduced~3-fold in mice containing five, 10 and 25 copies of the transgene. Their numbers rebounded, however, in higher copy number mice and increased beyond the control level. FACS analysis indicated that this elevation was a result of T cell activation as the frequency of CD44 hi CD45RB lo CD25 hi CD69 hi T cells increased significantly with gene copy number (Fig. 8) .
The hypertrophy of secondary lymphoid tissue was paralleled by a loss in normal architecture. For example, the PALS of the spleen, which contain the T cells that initiate primary humoral immune responses, was greatly expanded by lymphoid aggregates and myeloid hyperplasia. In mice with IBD this hyperplasia represented a moderate to severe defined as B and T cells were co-localized rather than appearing in distinct regions (Fig. 9) . Finally, the medullary regions of the nodes became greatly expanded with lympho- Fig. 5 . Colon from a control (A) and Lckgp39 (B) mouse (ϫ48). The transgenic mouse colon (line 7913; 50 copies) is thickened by a transmural infiltrate that results in glandular loss. The lung (C) from animals with a high transgene copy number contains a prominent mononuclear infiltrate around vessels and airways (ϫ120). There is effacement of mesenteric lymph node (D) architecture by a myeloid infiltrate in Lckgp39 mice (ϫ160). Immunohistochemical detection of a membranous glomerulopathy in Lckgp39 (F), but not control (E), kidneys (ϫ160). Deposits of IgG in the glomeruli of transgenic mouse kidneys was detected by immunoperoxidase staining (see Methods).
cytes and myeloid cells, the latter of which were primarily panied by an increased cellularity of peripheral lymphoid tissue containing abnormalities in organization and neutrophils in more diseased animals. These results indicate that the inflammation in Lckgp39 transgenic mice is accomfunction. Discussion ism is that it restricts the appearance of this potent regulatory signal and therefore protects against protracted or indiscriminThe expression of gp39 on peripheral T cells is activationate signaling with CD40 ϩ cells. Evidence that gp39 overexprdependent; gp39 appears on the cell surface within 1-3 h ession can cause immunological dysfunction was clearly following antigen recognition, reaches a peak level after 6-8 h demonstrated in Lckgp39 transgenic mice where, as a funcand then disappears by 24 h (4). While new gene expression tion of the Lck promoter and transgene copy number (32), contributes substantially to this response, we suggest that we observed an exponential loss of thymocytes that reached these kinetics are also influenced by a mechanism that three orders of magnitude. The dose-dependent decline in regulates gp39 transport to the cell surface. This conclusion these cells was also paralleled by a novel change in thymic is based on our analysis of thymocytes that constitutively architecture that was distinguished by the loss of ER-TR4 ϩ transcribed the Lckgp39 transgene. Nearly all (Ͼ95%) of the cortical epithelium and retention of a CD40-rich environment fresh thymocytes isolated from line 7918 (three transgenes) containing medullary epithelium (34) . contained intracellular gp39, but only 2-6% expressed gp39
Gene disruption experiments indicated that neither gp39 on their cell surface. The rapid release of gp39 following nor CD40 was required for T cell development (2,3), yet treatment with PMA and ionomycin argues that the mechanism functional CD40 is readily expressed in the thymus (23). gp39 retaining gp39 is activation-dependent, and the concordance is also detected in the normal thymus but only in a subset of between transgene copy number and increased surface thymocytes that we and others suggest are mostly CD4 ϩ CD8 -levels of gp39 in non-activated thymocytes suggests that this (24) . These cells are thought to accumulate within the CD40-mechanism is saturable. Supporting the existence of this rich medullary compartment during their maturation into helper phenomenon is the rapid surface mobilization of gp39 in T cells. Previous experiments suggest that gp39-CD40 internon-transgenic thymocytes and a similar effect observed in action may provide an essential co-stimulatory signal during peripheral CD4 ϩ T cells (40).
TCR-mediated negative selection (24) . If, in fact, this signaling The rapid delivery of gp39 to the plasma membrane could pathway was involved in shaping the T cell repertoire through facilitate the early phases of T cell interaction and prime thymocyte deletion, then its overexpression might be immunological responses in the absence of new gene transcription. Another critical feature of this sequestration mechanexpected to enhance negative selection. This would cause In addition to the thymus, the peripheral tissues of Lckgp39 antigen-rich environment is normally protected from immune attack by a regulatory system involving CD4 ϩ T cells (21). mice accumulated various abnormalities, the severity of which increased in a transgene dose-dependent manner. Most Alterations within this cell population, either through mutation (15-17), selection (18) or direct manipulation (43) , are thought noticeable was the incidence of inflammation and the hypertrophy of lymphoid tissue involving the loss of normal follicular to initiate immune dysregulation and disease. One mechanism that may explain the marked inflammation and lymphocyte structure and the co-localization of activated T cells and B cells in large lymphocytic clusters. Mononuclear infiltrates activation in Lckgp39 transgenic mice involves their thymus defect and the development of self-reactive T cells. Similar were apparent in tissues such as liver, lung, pancreas and the gastrointestinal tract in animals carrying Ͼ10 copies of to human CD3ε transgenic mice (18), the microenvironment of the gp39 thymus may favor aberrant T cell selection. This the transgene, and mice which contained 50 or more copies died from an IBD phenotype. Confirmation of the relationship perturbation, however, would have to involve more than a simple increase in negative selection, as this latter process between IBD and gp39 gene copy number was obtained by breeding experiments where matings between lines conmight actually reduce autoreactivity. One possibility is that Lckgp39 mice fail to develop regulatory T cells that suppress taining 25 and 40 copies, or 12 and 40 copies of Lckgp39 the development of colitis (18, 43) . In addition to a defect in thymus selection, the chronic inflammation in Lckgp39 mice may also be caused by the continuation of transgene expression in peripheral T cells. For instance, the increased levels of gp39 detected in these cells might stimulate B cell (44) and T cell proliferation (45) directly. The colitis, which is thought to be a T h 1-driven event (20) , may also be stimulated that inappropriate gp39 expression might enhance or prolong
